A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Enopace Biomedical

Enopace's implantable device

From Patent Application Publication: US 2011/0137370 A1

Enopace Biomedical Ltd. was founded in 2008 by Yossi Gross in Caesarea, Israel.

Very scant details are available besides that it is developing a neuromodulation system to treat patients with congestive heart failure. According to the company, its technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload.

From Enopace’s patent applications, it seems that Enopace’s device consists of a stimulation unit that is placed within the aorta close to the heart, and which is driven wirelessly from a coil that is placed within a vein closeby to the artery.  The transmitting coil is in turn driven from an implanted control unit that is implanted subcutaneously.

 In October 2011 Sorin invested $7 million to finance the initial clinical studies of Enopace’s technology as well as ongoing product development.

Company website: www.enopace.com

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Enopace Biomedical  comments